6-aminophenanthridine has been researched along with imiquimod in 1 studies
| Studies (6-aminophenanthridine) | Trials (6-aminophenanthridine) | Recent Studies (post-2010) (6-aminophenanthridine) | Studies (imiquimod) | Trials (imiquimod) | Recent Studies (post-2010) (imiquimod) |
|---|---|---|---|---|---|
| 10 | 0 | 9 | 3,264 | 284 | 1,963 |
| Protein | Taxonomy | 6-aminophenanthridine (IC50) | imiquimod (IC50) |
|---|---|---|---|
| Histamine H2 receptor | Homo sapiens (human) | 1.506 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 2.621 | |
| Adenosine receptor A2a | Homo sapiens (human) | 5.32 | |
| 7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens (human) | 0.646 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, D; Sanyal, S | 1 |
1 review(s) available for 6-aminophenanthridine and imiquimod
| Article | Year |
|---|---|
Protein folding activity of the ribosome (PFAR) -- a target for antiprion compounds.
Topics: Aminoquinolines; Binding Sites; Guanabenz; Humans; Imiquimod; Phenanthridines; Prion Diseases; Prions; Protein Folding; Ribosomes; RNA, Ribosomal | 2014 |